Hydroxychloroquine sulfate and chloroquine phosphate are oral prescription drugs approved to treat malaria and other diseases. Although there are no currently approved treatments for COVID-19, both drugs have shown activity in laboratory studies against coronaviruses, including SARS-CoV-2 (the virus that causes COVID-19). Anecdotal reports suggest that these drugs may offer some benefit in the treatment of hospitalized COVID-19 patients. Clinical trials are needed to provide scientific evidence that these treatments are effective.
FDA issues emergency use authorization for hydroxychloroquine sulfate, chloroquine phosphat
More from UncategorizedMore posts in Uncategorized »
- CDC Quietly Admits Masks Don’t Work
- CDC Illegally Inflated the COVID Fatality Number by at Least 1,600 Percent According To Study
- Video: President Trump’s State of the Union Address at CPAC 2021
- Florida’s COVID-19 Numbers Are Better Than California’s or New York’s, and Its Economy Thrives
- SITREP: Tracking Military Flights – Still No Sign of Air Force 1